Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Bioconjug Chem ; 16(6): 1399-410, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-16287236

RESUMO

Attempts to unravel the cell translocation mechanism of a growing number of cell-penetrating peptides (CPP) have revealed molecular determinants essential for internalization ability. The peptide sequence and the charge have been proposed to be the major factors in determining the membrane interaction mode and subsequent internalization pathway. Recent research in this field has shifted to search and design of novel CPPs with predefined vectorial properties and elucidation of the mechanism of cell entry of CPPs with high cargo delivery efficiency. Here we present a map of interaction modes with cell surface and intracellular traffic of transportan and its analogue TP10 complexed with fluorescently labeled avidin or streptavidin-gold conjugates. The protein cargo complexed with either peptide is transduced into HeLa and Bowes cells mostly in the endocytic vesicles with heterogeneous morphology and size as demonstrated by transmission electron microscopy (TEM) and confocal laser scanning fluorescence microscopy. Most of the induced vesicles are large, with 0.5-2 mum diameter, probably macropinosomes, but the complexes are present also in smaller vesicles, suggesting involvement of different pathways. Later the majority of complexes are translocated from the cell periphery into vesicles of perinuclear region and partly to lysosomes. A fraction of transportan-streptavidin complexes is present also freely in cytoplasm, both in the close vicinity of plasma membrane and more centrally, suggesting the escape from endosomal vesicles, since vesicles with discontinuous membrane were also detected by TEM. The cell-translocation process of transportan-protein complexes is temperature dependent and strongly inhibited at 8-10 degrees C and blocked at 4 degrees C when only interaction with the plasma membrane takes place.


Assuntos
Permeabilidade da Membrana Celular , Galanina/farmacocinética , Proteínas Recombinantes de Fusão/farmacocinética , Venenos de Vespas/farmacocinética , Vesículas Citoplasmáticas/metabolismo , Portadores de Fármacos/farmacocinética , Endocitose , Corantes Fluorescentes , Células HeLa , Humanos , Estreptavidina , Temperatura
2.
Br J Pharmacol ; 145(8): 1093-102, 2005 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-15937518

RESUMO

Cell-penetrating peptides such as antennapedia, TAT, transportan and polyarginine have been extensively employed for in vitro and in vivo delivery of biologically active peptides. However, little is known of the relative efficacy, toxicity and uptake mechanism of individual protein transduction domain-peptide conjugates, factors that will be critical in determining the most effective sequence. In the present study, we show by FACS analysis that unconjugated antennapedia, TAT, transportan and polyarginine demonstrate similar kinetic uptake profiles, being maximal at 1-3 h and independent of cell type (HeLa, A549 and CHO cell lines). A comparison of the magnitude of uptake of cell-penetrating peptide conjugates demonstrated that polyarginine=transportan>antennapedia>TAT. However, examination of cellular toxicity showed that antennapedia

Assuntos
Portadores de Fármacos/farmacocinética , Fragmentos de Peptídeos/farmacocinética , Sequência de Aminoácidos , Animais , Células CHO , Contagem de Células , Técnicas de Cultura de Células , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Cricetinae , Portadores de Fármacos/química , Portadores de Fármacos/toxicidade , Endocitose/efeitos dos fármacos , Galanina/química , Galanina/farmacocinética , Galanina/toxicidade , Produtos do Gene tat/química , Produtos do Gene tat/farmacocinética , Produtos do Gene tat/toxicidade , Humanos , Dados de Sequência Molecular , Fragmentos de Peptídeos/química , Fragmentos de Peptídeos/toxicidade , Peptídeos/química , Peptídeos/farmacocinética , Peptídeos/toxicidade , Proteínas Recombinantes de Fusão/química , Proteínas Recombinantes de Fusão/farmacocinética , Proteínas Recombinantes de Fusão/toxicidade , Venenos de Vespas/química , Venenos de Vespas/farmacocinética , Venenos de Vespas/toxicidade
3.
Eur Ann Allergy Clin Immunol ; 36(10): 375-86, 2004 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-15662966

RESUMO

UNLABELLED: Specific immunotherapy (SIT) is frequently used in the treatment of allergic diseases. However, the mechanisms by which SIT achieves clinical improvement remained unclear. We decided to study the in vivo kinetics of this therapy, using a nuclear medicine approach (leukocytes labelled with 99mTc-HMPAO) in patients on maintenance doses of specific immunotherapy with confirmed clinical efficacy. MATERIAL AND METHODS: We studied 13 allergic patients grouped according to different treatment schedules: subcutaneous aqueous allergenic extract (3 latex and 2 hymenoptera venom), subcutaneous depot extract (2 house dust mite and 2 pollens), subcutaneous modified allergens (2 pollens), sublingual extract (2 house dust mites). The control group included two allergic patients submitted to subcutaneous injections of bacterial extract (1 patient--positive control), and aqueous solution (1 patient). At the same time that the therapeutic allergen was administered subcutaneously, the autologous labelled white cells were injected intravenously in a peripheral vein in the contralateral arm. A thoracic dynamic acquisition of 60 mins, 64x64 matrix, 2 frame/min, in anterior view was performed. Static acquisition for 256x256 matrix, during 5 mins each at 60, 90, 120, 180, 240, 300 and 360 mins after the administration of the radiolabelled leukocytes, in thoracic (anterior and posterior), and abdominal view were performed. During the examination, the local erythema was monitored. A similar procedure was undertaken for Sublingual administration of immunotherapy. RESULTS: The inflammatory activity at the site of SIT injection (aqueous depot extract) started in the first hour and the increase was time related. For modified allergen extract and sublingual SIT the activity was present since the beginning of the administration. The ascendant lymphatic drainage, which was directed to the homolateral axillary region, to the lymphoid tissue of the upper mediastinum and to the anterior region of the neck began earlier. Thoracic focalisations were present for all the patients, whereas bowel focalisations were only observed for the subcutaneous route of administration. Sublingual SIT did not induce axillary or intestinal inflammatory focalisations, even though the patients had swallowed the allergenic extract. The uptake coefficient in individualized areas corrected to the uptake coefficient background was also studied. CONCLUSIONS: For the subcutaneous route of administration, except for glutaraldehyde-modified allergen, the local inflammatory activity at the allergenic injection site was significantly higher in depth and was time dependent, maintaining activity even after complete disappearance of the erythema and/or wheal. These results express a prompt inflammatory involvement of the immune system with this allergenic therapy, which was unexpected until now. We also observed differences concerning allergic diseases, the type of allergenic extracts and routes of administration.


Assuntos
Alérgenos/uso terapêutico , Quimiotaxia de Leucócito , Dessensibilização Imunológica , Administração Sublingual , Adulto , Alérgenos/administração & dosagem , Animais , Venenos de Abelha/administração & dosagem , Venenos de Abelha/farmacocinética , Venenos de Abelha/uso terapêutico , Preparações de Ação Retardada , Dessensibilização Imunológica/métodos , Eritema/etiologia , Feminino , Humanos , Hipersensibilidade Imediata/diagnóstico por imagem , Hipersensibilidade Imediata/terapia , Injeções Subcutâneas , Intestinos/diagnóstico por imagem , Intestinos/imunologia , Cinética , Látex/administração & dosagem , Látex/farmacocinética , Látex/uso terapêutico , Hipersensibilidade ao Látex/diagnóstico por imagem , Hipersensibilidade ao Látex/terapia , Transfusão de Leucócitos , Tecido Linfoide/diagnóstico por imagem , Tecido Linfoide/imunologia , Masculino , Pessoa de Meia-Idade , Pólen/efeitos adversos , Pyroglyphidae , Cintilografia , Compostos Radiofarmacêuticos , Tecnécio Tc 99m Exametazima , Distribuição Tecidual , Venenos de Vespas/administração & dosagem , Venenos de Vespas/farmacocinética , Venenos de Vespas/uso terapêutico
4.
Bioorg Med Chem ; 7(5): 811-4, 1999 May.
Artigo em Inglês | MEDLINE | ID: mdl-10400333

RESUMO

Philanthotoxins, noncompetitive inhibitors of the nicotinic acetylcholine receptor and various glutamate receptors, were found to be capable of mediating cation transport across lipid bilayers. With respect to the relatively weak binding constants of these amphiphilic polyamines to neuronal receptor proteins, this finding implies that their interaction with cell membranes might have to be considered in addition to that with protein receptors to fully understand the molecular mechanism of these neurotoxins.


Assuntos
Cátions/metabolismo , Poliaminas , Venenos de Vespas/metabolismo , Venenos de Vespas/farmacocinética , Antibacterianos/farmacocinética , Membrana Celular/efeitos dos fármacos , Gema de Ovo/química , Gramicidina/farmacocinética , Ionóforos/farmacocinética , Cinética , Espectroscopia de Ressonância Magnética , Fosfatidilcolinas/química , Espectrometria de Fluorescência , Espermina/farmacocinética , Fatores de Tempo , Valinomicina/farmacocinética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...